Abstract
Data suggest that device-guided paced respiration (<10 breaths/min) may reduce blood pressure in hypertensive patients. We hypothesized that daily device-guided slow breathing may lower blood pressure in patients with hypertension and obstructive sleep apnea (OSA). In this one-arm pilot study, we enrolled 25 subjects with hypertension and OSA. Subjects were asked to perform device-guided paced respiration 30 min a day for 8 weeks. Our primary outcome was change in office systolic and diastolic blood pressures from baseline to 8 weeks. Twenty-four subjects completed the study. Mean baseline blood pressure was 140.0 ± 10.2 mmHg systolic and 82.7 ± 8.9 mmHg diastolic. Complete device data were available for 17 subjects. Mean device adherence was 81 ± 24% and 51% achieved a mean breath rate ≤10 breaths/min over 8 weeks. Three subjects had changes in their anti-hypertensive medications during the study. Among the remaining 21 subjects, mean difference in office blood pressure from baseline to 8 weeks was −9.6 ± 11.8 mmHg systolic (p ≤ 0.01) and −2.52 ± 8.9 mmHg diastolic (p = 0.21). Device-guided paced respiration may lower systolic blood pressure in patients with hypertension and OSA; however, our findings need to be confirmed with larger randomized controlled trials.
Similar content being viewed by others
References
Resperate for hypertension. The Medical Letter on Drugs and Therapeutics, 1264, 55–56 (2007).
Alajmi, M., et al. (2007). Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: A meta-analysis of randomized controlled trials. Lung, 2, 67–72.
Altena, M. R., et al. (2009). Effect of device-guided breathing exercises on blood pressure in patients with hypertension. Blood Press, 18(5), 273–279.
Barnes, P. M., Bloom, B., & Nahin, R. L. (2008). Complementary and alternative medicine use among adults and children: United States, 2007. National Health Statistics Reports, 12, 1–23.
Bazzano, L. A., et al. (2007). Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension, 2, 417–423.
Bernardi, L., et al. (2001). Breathing patterns and cardiovascular autonomic modulation during hypoxia induced by simulated altitude. Journal of Hypertension, 5, 947–958.
Bernardi, L., et al. (2007). Reduced hypoxic ventilatory response with preserved blood oxygenation in yoga trainees and Himalayan Buddhist monks at altitude: Evidence of a different adaptive strategy? European Journal of Applied Physiology, 5, 511–518.
Botros, N., et al. (2009). Obstructive sleep apnea as a risk factor for type 2 diabetes. The American Journal of Medicine, 12, 1122–1127.
Chobanian, A. V., et al. (2003). The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA: The Journal of the American Medical Association, 19, 2560–2572.
Diaz, T., & Taylor, J. A. (2006). Probing the arterial baroreflex: Is there a ‘spontaneous’ baroreflex? Clinical Autonomic Research, 4, 256–261.
Elliot, W. J., et al. (2004). Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. The Journal of Clinical Hypertension (Greenwich), 10, 553–559.
Elliott, W. J., & Izzo, J. L., Jr. (2006). Device-guided breathing to lower blood pressure: Case report and clinical overview. Medscape General Medicine, 3, 23.
Hla, K. M., et al. (1994). Sleep apnea and hypertension. A population-based study. Annals of Internal Medicine, 5, 382–388.
Joseph, C. N., et al. (2005). Slow breathing improves arterial baroreflex sensitivity and decreases blood pressure in essential hypertension. Hypertension, 4, 714–718.
Laaban, J. P., et al. (2009). Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diabetes and Metabolism, 5, 372–377.
Logtenberg, S. J., et al. (2007). Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: A randomized controlled trial. Journal of Hypertension, 1, 241–246.
Nieto, F. J., et al. (2000). Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA: The Journal of the American Medical Association, 14, 1829–1836.
Nolan, R. P., et al. (2010). Behavioral neurocardiac training in hypertension: A randomized, controlled trial. Hypertension, 4, 1033–1039.
Oneda, B., et al. (2010). Sympathetic nerve activity is decreased during device-guided slow breathing. Hypertension Research, [Epub ahead of print].
Parati, G., et al. (2008). Device-guided paced breathing in the home setting: effects on exercise capacity, pulmonary and ventricular function in patients with chronic heart failure: A pilot study. Circulation Heart Failure, 3, 178–183.
Peppard, P. E., et al. (2000). Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine, 19, 1378–1384.
Pi-Sunyer, X. (2009). The medical risks of obesity. Postgraduate Medicine, 6, 21–33.
Raupach, T., et al. (2008). Slow breathing reduces sympathoexcitation in COPD. European Respiratory Journal, 2, 387–392.
Reyes del Paso, G. A., et al. (2006). Short-term effects of a brief respiratory training on baroreceptor cardiac reflex function in normotensive and mild hypertensive subjects. Applied Psychophysiology and Biofeedback, 1, 37–49.
Rosenthal, T., et al. (2001). Device-guided breathing exercises reduce blood pressure: Ambulatory and home measurements. Journal of Human Hypertension, 1, 74–76.
Schein, M. H., et al. (2001). Treating hypertension with a device that slows and regularises breathing: A randomised, double-blind controlled study. Journal of Human Hypertension, 4, 271–278.
Schein, M. H., et al. (2009). Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial. Journal of Human Hypertension, 5, 325–331.
Seals, D. R., Suwarno, N. O., & Dempsey, J. A. (1990). Influence of lung volume on sympathetic nerve discharge in normal humans. Circulation Research, 1, 130–141.
Seals, D. R., et al. (1993). Respiratory modulation of muscle sympathetic nerve activity in intact and lung denervated humans. Circulation Research, 2, 440–454.
Somers, V. K., et al. (1995). Sympathetic neural mechanisms in obstructive sleep apnea. The Journal of Medical Investigation, 4, 1897–1904.
Vgontzas, A. N. (2008). Does obesity play a major role in the pathogenesis of sleep apnoea and its associated manifestations via inflammation, visceral adiposity, and insulin resistance? Archives of Physiology and Biochemistry, 4, 211–223.
Viskoper, R., et al. (2003). Nonpharmacologic treatment of resistant hypertensives by device-guided slow breathing exercises. Journal of Human Hypertension, 6, 484–487.
Whelton, P. K., et al. (2002). Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA: The Journal of the American Medical Association, 15, 1882–1888.
Young, T., et al. (1997). Population-based study of sleep-disordered breathing as a risk factor for hypertension. Archives of Internal Medicine, 15, 1746–1752.
Acknowledgments
This work was supported by an investigator-initiated grant from Philips-Respironics. Dr. Bertisch was supported by an Institutional National Research Service Award (T32AT00051-06) and by a career development award (1 K23 AT005104-01) from the National Center for Complementary and Alternative Medicine (NCCAM), NIH. Dr. Malhotra was supported by grants from the NHLBI (R01 HL73146, R01 HL085188-01, R01 HL090897-01, K24 HL 093218) and the American Heart Association (AHA 0840159 N). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NHLBI, NCCAM, or the National Institutes of Health.
Conflicts of Interest
Dr. Bertisch has received consulting fees from Philips. Dr. Malhotra has received consulting and/or research income from Philips, Ethicon, Apnex, SGS, SHC, Merck, Apnicure, Medtronic, Pfizer, Cephalon, Sepracor. Dr. Baloa, Lauren Hueser and Stephen Pittman are employees of Philips. This study investigated an off-label use of bi-level positive airway pressure (BiPAP® Pro 2, Philips Respironics, Murrysville, PA).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bertisch, S.M., Schomer, A., Kelly, E.E. et al. Device-Guided Paced Respiration as an Adjunctive Therapy for Hypertension in Obstructive Sleep Apnea: A Pilot Feasibility Study. Appl Psychophysiol Biofeedback 36, 173–179 (2011). https://doi.org/10.1007/s10484-011-9158-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10484-011-9158-x